or Try an Advanced Search...

    Technical Analysis for KRRO - Korro Bio, Inc.

    Grade Last Price % Change Price Change
    D 50.50 7.45% 3.50
    KRRO closed up 0.79 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Down
    Historical KRRO trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 7.45%
    Lower Bollinger Band Walk Weakness 7.45%
    Wide Bands Range Expansion 7.45%
    Oversold Stochastic Weakness 7.45%
    MACD Bearish Centerline Cross Bearish 8.30%
    Stochastic Buy Signal Bullish 8.30%
    Calm After Storm Range Contraction 8.30%
    NR7 Range Contraction 8.30%
    Narrow Range Bar Range Contraction 8.30%
    Lower Bollinger Band Walk Weakness 8.30%
    Older End-of-Day Signals for KRRO ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 14 minutes ago
    60 Minute Opening Range Breakout 32 minutes ago
    Rose Above 50 DMA 32 minutes ago
    Rose Above Previous Day's High about 4 hours ago
    Up 5% about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KRRO Chart by TradingView
    Basic chart:

    Profile

    Korro is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling treatment of both rare and highly prevalent diseases. Korro's lead program in AATD has demonstrated an increase of normal A1AT protein up to 85% of total A1AT protein in circulation in in vivo preclinical studies, which has the potential of disease-modifying effects and providing a differentiated therapeutic option.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Hepatology Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency

    Is KRRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 21 Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
    Nov 14 Korro to Present at the Jefferies London Healthcare Conference
    Nov 13 Korro Bio GAAP EPS of -$2.26
    Nov 12 Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates
    Nov 4 Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board
    Oct 21 Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
    Oct 16 Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
    Sep 30 Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
    Sep 16 Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
    Sep 4 Will Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?
    See more KRRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 98.0
    52 Week Low 30.005
    Average Volume 135,358
    200-Day Moving Average 51.58
    50-Day Moving Average 50.47
    20-Day Moving Average 60.15
    10-Day Moving Average 57.07
    Average True Range 7.27
    RSI (14) 38.27
    ADX 23.35
    +DI 21.37
    -DI 23.94
    Chandelier Exit (Long, 3 ATRs) 55.32
    Chandelier Exit (Short, 3 ATRs) 66.46
    Upper Bollinger Bands 77.22
    Lower Bollinger Band 43.08
    Percent B (%b) 0.11
    BandWidth 56.75
    MACD Line -1.53
    MACD Signal Line 1.58
    MACD Histogram -3.113
    Fundamentals Value
    Market Cap 376.54 Million
    Num Shares 8.01 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 53.24
    Resistance 3 (R3) 53.37 51.41 52.20
    Resistance 2 (R2) 51.41 49.82 51.35 51.85
    Resistance 1 (R1) 49.21 48.84 50.31 49.08 51.51
    Pivot Point 47.25 47.25 47.81 47.19 47.25
    Support 1 (S1) 45.05 45.66 46.15 44.92 42.49
    Support 2 (S2) 43.09 44.68 43.03 42.15
    Support 3 (S3) 40.89 43.09 41.80
    Support 4 (S4) 40.76